SCHEMBL4976292

SCHEMBL4976292

CCOc1ccc(C(=O)N2CCc3cnc(N4CCN(C5CCC5)CC4)nc3CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.48
KDM4E B2RXH2 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 1/20 0.47
HSD17B10 Q99714 1/20 0.47
HSP90AB1 P08238 4/20 0.47
HRH3 Q9Y5N1 4/20 0.45
KDM2B Q8NHM5 1/20 0.44
GAA P10253 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPT P10636 3/20 0.42
PKM P14618 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4978516 0.93 HSP90AB1 (0.46) HPGDALDH1A1HSP90AB1HRH3KDM2B
SCHEMBL4981523 0.93 HPGD (0.50) HPGDL3MBTL1ALDH1A1HSP90AB1HRH3
SCHEMBL4980394 0.91 KDM2B (0.55) HPGDKDM4EHSP90AB1HRH3KDM2B
SCHEMBL4975212 0.90 KDM2B (0.47) HPGDKDM4EL3MBTL1ALDH1A1HSP90AB1
SCHEMBL4975122 0.89 MAPT (0.48) HPGDKDM4EL3MBTL1ALDH1A1HSP90AB1
SCHEMBL4977984 0.89 HSP90AB1 (0.47) KDM4EHSP90AB1HRH3KDM2BMAPT
SCHEMBL4979058 0.88 KDM2B (0.53) L3MBTL1HSP90AB1HRH3KDM2BMEN1
SCHEMBL4980183 0.88 MEN1 (0.49) L3MBTL1HSD17B10HSP90AB1HRH3KDM2B
SCHEMBL4976026 0.88 HRH3 (0.54) KDM4EALDH1A1HSP90AB1HRH3KDM2B
SCHEMBL4976638 0.87 HSP90AB1 (0.47) L3MBTL1HSP90AB1HRH3KDM2BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES HRH3, HRH4, HRH2 HPGD 159/4885KDM4E 1865/4885L3MBTL1 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.